Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
3/10/25 16:43 | 12/15/23 | BBIO | Health | Drug | Pharmaceutical Preparations | Valantine Hannah | CA | D | 5 | S.d | -833 | 33.95 | 0 | -25 | 5 | D | ||||||||||||||||
3/7/25 18:09 | 3/5/25 | BBIO | Financ | InvAdv | Investment Advice | Kkr Genetic Disorder L.P. | NY | T | 2 | S | -347,110 | 29.42 | 0 | -11,800 | 25,261 | I | ||||||||||||||||
2/27/25 17:36 | 11/17/23 | BBIO | Health | Drug | Pharmaceutical Preparations | Stephenson Brian C | CA | O | CFO,Trea | 6 | S.d | -3,756 | 33.64 | 0 | -112 | 102 | D | |||||||||||||||
2/27/25 17:12 | 11/17/23 | BBIO | Health | Drug | Pharmaceutical Preparations | Kumar Neil | CA | DO | CEO | 6 | S.dm | -28,237 | 34.74 | 0 | -813 | 6,906 | D | |||||||||||||||
1/31/25 19:18 | 1/31/25 | BBIO | Health | Drug | Pharmaceutical Preparations | Viking Global Investors LP | CT | T | 1 | S | -106,990 | 34.90 | 0 | -3,066 | 22,055 | I | ||||||||||||||||
6/5/24 16:53 | 12/18/23 | BBIO | Health | Drug | Pharmaceutical Preparations | Scott Randal W. | CA | D | 4 | S.m | -314 | 33.08 | 0 | -10 | 16 | I | ||||||||||||||||
12/28/23 16:00 | 12/26/23 | BBIO | Health | Drug | Pharmaceutical Preparations | McCormick Frank | CA | D | 1 | S | -4,206 | 42.06 | 0 | -100 | 1,100 | I |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |